Skip to main content
Top
Published in: Medical Microbiology and Immunology 2/2010

01-05-2010 | Rapid Communication

Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathy

Authors: Tomas Palecek, Petr Kuchynka, Dagmar Hulinska, Jana Schramlova, Hana Hrbackova, Ivana Vitkova, Stanislav Simek, Jan Horak, William E. Louch, Ales Linhart

Published in: Medical Microbiology and Immunology | Issue 2/2010

Login to get access

Abstract

Dilated cardiomyopathy (DCM) represents the third most common cause of heart failure and the most frequent cause of heart transplantation. Infectious, mostly viral, and autoimmune mechanisms, together with genetic abnormalities, have been reported as three major causes of DCM. We hypothesized that Lyme disease (LD), caused by spirochete Borrelia burgdorferi (Bb), might be an important cause of new-onset unexplained DCM in patients living in a highly endemic area for LD such as the Czech Republic. We performed endomyocardial biopsy (EMB) in 39 consecutive patients presenting with symptomatic unexplained left ventricular (LV) systolic dysfunction lasting no more than 12 months. In eight subjects (21%), Bb was detected in the EMB sample by polymerase chain reaction or by electron microscopy. None of these patients exhibited any form of atrioventricular block or other extracardiac manifestation of Bb infection. Serological testing identified IgG antibodies against Bb in only two cases and IgM antibodies in none. All affected patients were treated with intravenous ceftriaxone for 3 weeks. At 6 months follow-up, LV morphology and function as well as functional status of these patients significantly improved. In conclusion, Bb infection may represent an important cause of new-onset unexplained DCM in patients living in endemic regions such as the Czech Republic. Because the antibiotic treatment appears to be markedly effective and serological examination does not provide a tool for diagnosing the disease, EMB focused on the detection of Bb should be performed in all patients from endemic areas with new-onset unexplained DCM not responding to conventional therapy.
Literature
1.
go back to reference Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuwelt S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270–276CrossRefPubMed Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuwelt S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270–276CrossRefPubMed
2.
go back to reference Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (2006) Contemporary definitions and classification of cardiomyopathies. Circulation 113:1807–1816CrossRefPubMed Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (2006) Contemporary definitions and classification of cardiomyopathies. Circulation 113:1807–1816CrossRefPubMed
3.
go back to reference Kühl U, Pauschinger M, Noutsias M, Kapp JF, Schultheiss HP (2002) Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy. Eur Heart J 4(Suppl I):I73–I80 Kühl U, Pauschinger M, Noutsias M, Kapp JF, Schultheiss HP (2002) Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy. Eur Heart J 4(Suppl I):I73–I80
5.
6.
go back to reference Bartunek P, Gorican K, Veiser T, Taborsky M, Hulinska D (2007) Significance of Borrelia infection in development of dilated cardiomyopathy (a pilot study). Prague Med Rep 108:339–347PubMed Bartunek P, Gorican K, Veiser T, Taborsky M, Hulinska D (2007) Significance of Borrelia infection in development of dilated cardiomyopathy (a pilot study). Prague Med Rep 108:339–347PubMed
7.
go back to reference Franz JK, Krause A (2003) Lyme disease (Lyme borreiolosis). Best Pract Res Clin Rheumatol 17:241–264CrossRefPubMed Franz JK, Krause A (2003) Lyme disease (Lyme borreiolosis). Best Pract Res Clin Rheumatol 17:241–264CrossRefPubMed
8.
go back to reference Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography′s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography′s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed
9.
go back to reference Weyman AE, Doty WD (1982) Left ventricle. In: Weyman AE (ed) Cross sectional echocardiography. Lea and Febiger, Philadelphia, p 267 Weyman AE, Doty WD (1982) Left ventricle. In: Weyman AE (ed) Cross sectional echocardiography. Lea and Febiger, Philadelphia, p 267
11.
go back to reference Kühl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic inflammatory process in dilated cardiomyopathy. Heart 75:295–300CrossRefPubMed Kühl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic inflammatory process in dilated cardiomyopathy. Heart 75:295–300CrossRefPubMed
12.
go back to reference Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111:887–893CrossRefPubMed Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111:887–893CrossRefPubMed
13.
go back to reference Lelovas P, Donbas I, Bassiakou E, Xanthos T (2008) Cardiac implications of lyme disease, diagnosis and therapeutic approach. Int J Cardiol 129:15–21CrossRefPubMed Lelovas P, Donbas I, Bassiakou E, Xanthos T (2008) Cardiac implications of lyme disease, diagnosis and therapeutic approach. Int J Cardiol 129:15–21CrossRefPubMed
14.
go back to reference Pankuweit S, Hufnagel G, Eckhardt H, Hermann H, Uttecht S, Maisch B (1998) Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation. Med Klin (Munich) 93:223–228CrossRef Pankuweit S, Hufnagel G, Eckhardt H, Hermann H, Uttecht S, Maisch B (1998) Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation. Med Klin (Munich) 93:223–228CrossRef
15.
16.
go back to reference Stanek G, Klein J, Bittner R, Glogar D (1990) Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 322:249–252PubMedCrossRef Stanek G, Klein J, Bittner R, Glogar D (1990) Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 322:249–252PubMedCrossRef
17.
go back to reference Suedkamp M, Lissel C, Eiffert H, Flesch M, Boehm M, Mehlhorn U, Thomssen R, de Vivie ER (1999) Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J 138:1198–1199CrossRef Suedkamp M, Lissel C, Eiffert H, Flesch M, Boehm M, Mehlhorn U, Thomssen R, de Vivie ER (1999) Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J 138:1198–1199CrossRef
18.
go back to reference Gasser R, Dusleag J, Reisinger E, Stauber R, Feigl B, Pongratz S, Klein W, Furian C, Pierer K (1992) Reversal by ceftriaxone of dilated cardiomyopathy borrelia burgdorferi infection. Lancet 339:1174–1175CrossRefPubMed Gasser R, Dusleag J, Reisinger E, Stauber R, Feigl B, Pongratz S, Klein W, Furian C, Pierer K (1992) Reversal by ceftriaxone of dilated cardiomyopathy borrelia burgdorferi infection. Lancet 339:1174–1175CrossRefPubMed
19.
go back to reference Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39–45CrossRefPubMed Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39–45CrossRefPubMed
20.
go back to reference Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107:857–863CrossRefPubMed Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107:857–863CrossRefPubMed
21.
go back to reference Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, Hoher M, Hombach V, Torzewski J (2005) Myocardial biopsy based classification and treatment in patiens with dilated cardiomyopathy. Int J Cardiol 104:92–100CrossRefPubMed Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, Hoher M, Hombach V, Torzewski J (2005) Myocardial biopsy based classification and treatment in patiens with dilated cardiomyopathy. Int J Cardiol 104:92–100CrossRefPubMed
Metadata
Title
Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathy
Authors
Tomas Palecek
Petr Kuchynka
Dagmar Hulinska
Jana Schramlova
Hana Hrbackova
Ivana Vitkova
Stanislav Simek
Jan Horak
William E. Louch
Ales Linhart
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 2/2010
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-009-0141-6

Other articles of this Issue 2/2010

Medical Microbiology and Immunology 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.